Turn Therapeutics Inc. (NASDAQ: TTRX) is a Healthcare company (Biotechnology) with a market capitalization of $261M. The Maz Rating grades it against the other companies in its sector.
Turn Therapeutics Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $8.55, Turn Therapeutics Inc. trades at 45.5x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -297.3%, return on invested capital of -52.8% and a free cash flow yield of -2.0%. On the balance sheet: a debt-to-equity ratio of 0.09 and a current ratio of 3.19. Over the past 52 weeks the share price ranged from $2.57 to $16.45, with a beta of 2.04.
Turn Therapeutics Inc. does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 1 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.